From molecule to market
We are your trusted partner for the secure transport of commercial drugs throughout the product lifecycle. With decades of experience executing complex logistics programs, our expansive reach gives us the flexibility to support your entire manufacturing network across global markets, providing end-to-end visibility and security when transporting everything from API to high-value commercial products.
We leverage our expertise in the clinical trial space to add value to your commercial supply chain. We specialize in the transport of high-value, low-volume shipments with strict temperature control requirements—particularly liquid formulations and drugs with short shelf-lives. As experts in navigating complicated regulatory environments, we handle complex lanes and customs challenges regularly. Focusing on oncology and rare diseases, our portfolio includes the shipping of active pharmaceutical ingredient (API) and temperature-controlled specialty drugs, like biosimilars, orphan and cytostatic drugs.
Execution without excursions
Our diverse portfolio of temperature control solutions offer increased flexibility for your supply chain.
With a variety of active and passive solutions available in a range of sizes, our temperature control experts help you find the right shipping solution to maintain your product's requirements throughout its journey. That means that for unpredictable, demand-based supply chains, we have the flexibility to ship low-volume, high-value drugs in appropriately-sized containers quickly and efficiently.
Cocoon, our proprietary passive shipping solution, is revolutionizing the transport of pallet-sized shipments. Qualified for 168 hours of temperature stability, Cocoon increases your access to global markets. And since Cocoon was developed by our very own CORE Labs, we are independent from external thermal container contractors—leading to considerable cost savings and flexibility that we pass on to you.
Through our Climate Optimisation Research and Engineering (CORE) Labs, we provide on-demand qualification data for any solution you need tested—driving decision making and supporting regulatory and GxP compliance. That means you can choose the most cost-effective solution for your transport route, without compromising the safety and efficacy of your product.
We understand that building a strong partnership demands a complete understanding of—and alignment with—your business goals. Our clinical trial expertise enables us to provide our customers with individualized solutions regarding flexibility, supply chain visibility and security, no matter if it is a single dosage or a bulk shipment. That means a commitment to improving global health with custom programs driven by a thorough assessment of risk factors and a focus on the integrity of each shipment. It also means dedicated account managers for every customer and a collaborative approach that helps you maximize the financial return on your R&D investments, instilling confidence in our ability to help you meet business objectives.
Commercialization support from AmerisourceBergen
AmerisourceBergen’s family of companies delivers unmatched commercialization expertise. Whether leveraging market access and reimbursement support from Xcenda, or wholesale commercialization and distribution support from ICS, our portfolio of services will help increase your speed-to-market and drive your ultimate goal—improving global healthcare.Explore our network
Cell and Gene Therapy
As more cell and gene therapies move through clinical trials and advance toward a commercial launch, innovators must overcome unprecedented regulatory and logistical challenges. In many cases, this will require redefining established approaches within many areas of commercialization. As the logistics partner in over half of active cell and gene therapy studies, we’ve refined a patient-centric supply chain model that employs extensive contingency planning and communication to ensure unexpected complications don’t impact your deliveries.
In Australasia, we support patient adherence programs through commercial Direct-to-Patient services. Employing a patient-centric logistical model, these manufacturer-sponsored programs ease the burden of care by administering life-saving treatments where patients are most comfortable, in close collaboration with home health providers. Our associates leverage monitoring solutions to provide proof upon delivery that environmental requirements were maintained throughout transport, ensuring product safety before administration.
Quality beyond compliance
Quality begins with strict adherence to global GxP standards. But for highly-complex, high-value shipments, there is zero room for deviation or failure. We strive for ‘quality beyond compliance’ at the global level to ensure even greater attention to detail and a single-minded focus on perfection.